ALERT! Canada’s Goldman Sachs Revealed

GMP Capital Inc (TSX:GMP) trades at a reasonable price and has huge opportunity to gain market share in Canada’s growing investment banking industry. Does the company’s improved financial performance make it a buy?

GMP Capital (TSX:GMP) is an independent diversified financial services company and provides various financial products and services to corporate clients, institutional investors, and high-net-worth individuals in Canada, the United States, and globally.

It operates in two segments: Capital Markets and Wealth Management. The Capital Markets segment offers investment banking services, including advisory and underwriting services, institutional research and sales, and brokerage services.

The Wealth Management segment provides wealth management and investment services. The company was incorporated in 1995 and corporate headquarters are in Toronto, Ontario.

The company is very reasonably priced with a price to book value of 1.07 and market capitalization of 154 million. Debt is very sparingly used at GMP Capital, as is evidenced by a debt to equity ratio of just 0.13.

The company has sub par performance metrics due to recent operational challenges, with an operating margin of 8.20% and a return on equity of (6.67)%.

In the most recent quarter, the company grew revenue by 15% and grew investment banking revenue by 46% year over year due to the company’s exposure to high growth cannabis, blockchain and energy sectors.

Non-commodities businesses accounted for 70% of total investment banking revenue and return on equity was 17.4%. Management seem committed to build shareholder value and returned $23.1 million to shareholders through common stock dividends and share repurchases.

The company pays a regular quarterly cash dividend of $0.025 per common share and declares special cash dividends periodically when the company expects an improving outlook and delivers improved financial performance amid strong capital levels.

In 2018, Canadian independent dealers benefited from significant capital raising and advisory activity by domestic and U.S. cannabis companies.

The Canadian capital markets experienced a surge in cannabis listings, with initial support from Canadian investors giving way to capital inflows from an increasingly international investor base.

GMP Capital was named a top cannabis influencer/financier in the Financial Post’s Cannabis Power List. The company helped cannabis companies raise $3.7 billion in total capital in 2018, and advised on the first-ever merger between two public U.S. cannabis companies.

The company has benefited from substantial reductions to the fixed cost side of the business and has exited certain under-performing and underutilized businesses in international jurisdictions, as is illustrated by the company’s sale of the U.S. fixed income business in early 2019.

The company also streamlined the Canadian capital markets business to better align operations with the current level of business opportunities in the marketplace.

GMP Capital currently owns 33% of Toronto-based Richardson GMP Ltd. Richardson GMP is engaged in the high-margin wealth management business.

Richardson recorded adjusted earnings before interest, taxes, depreciation, and amortization of $45.4 million on total revenue of $290.1 million in 2018.

Total assets under administration ended the year at $27.2 billion administered by 165 advisory teams. Richardson GMP strives to grow aggressively by leveraging the company’s unique positioning in Canada’s wealth management industry landscape. The company is making significant investments in new technologies and has launched a refreshed and revitalized brand.

GMP Capital is reasonably priced and appears to be a great way for Canadian investors to gain exposure to the growing investment banking industry in Canada.

Fool contributor Nikhil Kumar has no position in any of the stocks mentioned. The Motley Fool recommends GMP Capital Inc.

More on Investing

Financial analyst reviews numbers and charts on a screen
Dividend Stocks

2 Blue-Chip Stocks Every Canadian Should Own

These two top blue-chip stocks are some of the best companies in Canada, making them ideal investments for every Canadian.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

dividends can compound over time
Dividend Stocks

High-Yield Alert: 3 Canadian Dividend Stocks to Buy Now

These three high-yield dividend stocks all offer sustainable yields above 6%, making them some of the best stocks Canadians can…

Read more »

woman checks off all the boxes
Investing

Age 65 Checklist: 3 Things You Need to Do for a Big and Beautiful Retirement

Let's put together a checklist for Canadians entering retirement, and pinpoint some critical things to do to ensure the best…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

Got $14,000? How to Structure a TFSA for Constant Monthly Income

Build a TFSA monthly paycheque by pairing a steady apartment REIT with a higher‑yield lender, and using simple risk checks…

Read more »

the word REIT is an acronym for real estate investment trust
Dividend Stocks

A Perfect TFSA Stock: A 7.4% Payout Each Month

Automotive Properties REIT is a TSX dividend stock that offers you a monthly payout and a yield of 7.4% in…

Read more »

Canada day banner background design of flag
Investing

3 Reasons Why Canadian Stocks Could Have Another Banner Year in 2026

Here are three reasons why Canadian stocks could be poised for another banner year in 2026 as global investors seek…

Read more »

Pumps await a car for fueling at a gas and diesel station.
Dividend Stocks

1 Canadian Stock That’s an Easy ‘Yes’

A simple, steady compounder. Why Couche‑Tard’s Circle K model can be an “easy yes” for a TFSA without needing a…

Read more »